Price History
Investment Checklist
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Trend
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Price Action
Support & Resistance Levels
Volume Analysis
Stop Loss Levels
Fixed Risk
Technical Levels
Moving Averages
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹5,123.5 Cr | ₹6,290.2 Cr | ₹6,467 Cr | ₹6,780.4 Cr |
| Net Profit | ₹1,023.5 Cr | ₹1,170.9 Cr | ₹1,466.8 Cr | ₹1,042.1 Cr |
| EPS | ₹10.17 | — | ₹14.58 | ₹10.36 |
| Operating Profit | ₹1,445.1 Cr | ₹1,914.1 Cr | ₹2,243.4 Cr | ₹1,842.9 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
| BIOCON | Biocon Limited | ₹419.00 | +0.73% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 29 May 2026 | Buy Back | BUYBACK |
| 25 Jul 2025 | Dividend - Rs 11 Per Share | DIVIDEND |
| 26 Jul 2024 | Dividend - Rs 3 Per Share | DIVIDEND |
| 23 Feb 2024 | Buy Back | BUYBACK |
| 28 Jul 2023 | Dividend - Rs 6 Per Share | DIVIDEND |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for ZYDUSLIFE
View All
Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a month
The Sensex ended marginally higher, while four BSE 200 stocks touched fresh 52-week highs, signaling strong investor confidence. Zydus Lifesciences, Apollo Hospitals, Federal Bank and Adani Ports reached their highest levels in a year, supported by steady recent gains.
Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?
Investors have a final opportunity to tender shares in buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems and Software. These offers, collectively valued at approximately Rs 1,185 crore, are closing on Wednesday. Eligible shareholders can participate in these corporate actions, which represent a chance to sell shares at a premium.
Zydus Lifesciences receives USFDA warning letter for Baddi facility
Zydus Lifesciences said the USFDA has issued a warning letter for its Baddi manufacturing facility over observations related to purified talc specifications. The company said the communication does not relate to an on-site inspection and is not expected to impact operations or supplies.